The biotech drug market
نویسندگان
چکیده
منابع مشابه
Market Sensitivity and Methods to Ensure Tolerance of Biotech and Non-biotech Alfalfa Production Systems
Roundup-Ready® alfalfa was released in June of 2005, the first trait to be commercialized in alfalfa (Medicago sativa L.) using biotechnology. Traditional alfalfa varieties will likely be grown in close proximity to these new biotech varieties. While most users will probably not be sensitive to the presence of these varieties, other markets (particularly export and organic) will request hay tha...
متن کاملTargeting Biotech Drugs Nanosized Lipid Particles versus Drug Nanocrystals
Nanotechnology and, in particular, the development of nanosized delivery systems for biotech drugs (namely peptides, proteins and oligonucleotides), is a multidisciplinary field undergoing exponential development in the latest years [1-3]. The rate of these developments has been dictated in parallel by the progress of biotechnology. Biotechnological techniques have expanded the variety of thera...
متن کاملThe impact of seed industry concentration on innovation: a study of US biotech market leaders
Agricultural research drives increases in agricultural productivity, and the number of private agricultural input firms has been declining. The empirical relationship between the number of firms doing applied biotechnology crop research and the amount of research output they produce is investigated in a research profit function model. Increases in seed industry concentration have reduced biotec...
متن کاملTalking biotech with the public.
In the estimation of risks involved in complex technical applications, such as, for example, gene technology or nanotechnology, the problem of communication between science and the wider society becomes evident. The path towards transparent, authentic and credible communication must be built upon the reconciliation of the risk perceptions of the scientist--and of his or her institution--with th...
متن کاملthe test for adverse selection in life insurance market: the case of mellat insurance company
انتخاب نامساعد یکی از مشکلات اساسی در صنعت بیمه است. که ابتدا در سال 1960، توسط روتشیلد واستیگلیتز مورد بحث ومطالعه قرار گرفت ازآن موقع تاکنون بسیاری از پژوهشگران مدل های مختلفی را برای تجزیه و تحلیل تقاضا برای صنعت بیمه عمر که تماما ناشی از عدم قطعیت در این صنعت میباشد انجام داده اند .وهدف از آن پیدا کردن شرایطی است که تحت آن شرایط انتخاب یا کنار گذاشتن یک بیمه گزار به نفع و یا زیان شرکت بیمه ...
15 صفحه اولذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature Biotechnology
سال: 2004
ISSN: 1087-0156,1546-1696
DOI: 10.1038/nbt1204-1496